These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 24452095)
41. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy. Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106 [TBL] [Abstract][Full Text] [Related]
42. Boron neutron capture therapy for glioblastoma. Yamamoto T; Nakai K; Matsumura A Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207 [TBL] [Abstract][Full Text] [Related]
43. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry. Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510 [TBL] [Abstract][Full Text] [Related]
44. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748 [TBL] [Abstract][Full Text] [Related]
45. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium. Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908 [TBL] [Abstract][Full Text] [Related]
46. Subcellular boron-10 localization in glioblastoma for boron neutron capture therapy with Na2B12H11SH. Haselsberger K; Radner H; Gössler W; Schlagenhaufen C; Pendl G J Neurosurg; 1994 Nov; 81(5):741-4. PubMed ID: 7931621 [TBL] [Abstract][Full Text] [Related]
48. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion. Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171 [TBL] [Abstract][Full Text] [Related]
49. Mutagenic effect of borocaptate sodium and boronophenylalanine in neutron capture therapy. Kinashi Y; Masunaga S; Ono K Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):562-7. PubMed ID: 12243836 [TBL] [Abstract][Full Text] [Related]
50. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT). Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727 [TBL] [Abstract][Full Text] [Related]
51. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091 [TBL] [Abstract][Full Text] [Related]
52. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA. Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859 [TBL] [Abstract][Full Text] [Related]
53. Peptide-functionalized gold nanoparticles for boron neutron capture therapy with the potential to use in Glioblastoma treatment. Zhang Z; Wang X; Dai Q; Qin Y; Sun X; Suzuki M; Ying X; Han M; Wei Q Pharm Dev Technol; 2024 Oct; 29(8):862-873. PubMed ID: 39286881 [TBL] [Abstract][Full Text] [Related]
54. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940 [TBL] [Abstract][Full Text] [Related]
56. Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy. Laird M; Matsumoto K; Higashi Y; Komatsu A; Raitano A; Morrison K; Suzuki M; Tamanoi F Nanoscale Adv; 2023 May; 5(9):2537-2546. PubMed ID: 37143818 [TBL] [Abstract][Full Text] [Related]
57. Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord model. Morris GM; Coderre JA; Hopewell JW; Micca PL; Nawrocky MM; Liu HB; Bywaters A Radiother Oncol; 1994 Sep; 32(3):249-55. PubMed ID: 7816943 [TBL] [Abstract][Full Text] [Related]
58. From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy. Barth RF Appl Radiat Isot; 2015 Dec; 106():22-8. PubMed ID: 26149807 [TBL] [Abstract][Full Text] [Related]
59. Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with Fukuda H Cells; 2021 Oct; 10(11):. PubMed ID: 34831105 [TBL] [Abstract][Full Text] [Related]
60. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells. Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]